scutellarin has been researched along with Encephalopathy, Traumatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, P; Li, F; Wang, X; Zhang, X; Zhang, Z | 1 |
| Chen, K; Chen, ZW; Dong, XJ; Hu, Y; Jiang, L; Liu, J; Wang, KH; Wang, TH; Xia, QJ | 1 |
2 other study(ies) available for scutellarin and Encephalopathy, Traumatic
| Article | Year |
|---|---|
Breviscapine provides a neuroprotective effect after traumatic brain injury by modulating the Nrf2 signaling pathway.
Topics: Animals; Apoptosis; Brain; Brain Injuries, Traumatic; Disease Models, Animal; Flavonoids; Heme Oxygenase-1; In Situ Nick-End Labeling; Male; NAD(P)H Dehydrogenase (Quinone); Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Signal Transduction; Up-Regulation | 2019 |
Neuroprotective effect of breviscapine on traumatic brain injury in rats associated with the inhibition of GSK3β signaling pathway.
Topics: Animals; Apoptosis; Brain; Brain Injuries, Traumatic; Caspase 3; Disease Models, Animal; Flavonoids; Glycogen Synthase Kinase 3 beta; Male; Neuroprotective Agents; Phosphorylation; Random Allocation; Rats, Sprague-Dawley; Recovery of Function; RNA, Messenger; Signal Transduction; Synaptophysin | 2017 |